Cited by 189Stress Responses and CortisolAdrenal Hormones and DisordersNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor

Open access

DeBold, C R, Sheldon, W R, DeCherney, G S, Jackson, R V, Alexander, A N, Vale, W, Rivier, J, Orth, D N·1984·Journal of Clinical Investigation

DOI 10.1172/jci111240PMC PMC425045

Open this paper in CoChat — free account Open PDF

Abstract

Arginine vasopressin (AVP) stimulates ACTH release in man and acts synergistically with synthetic ovine corticotropin-releasing factor (oCRF) in vitro. This study was designed to examine in man the combined effects of synthetic AVP (10 U intramuscularly) and oCRF (1 micrograms/kg intravenously) on ACTH release. Five normal male volunteers participated in five separate experiments: (a) AVP alone; (b) oCRF alone; (c) AVP followed by oCRF 15 min later; (d) simultaneous AVP and oCRF; and (e) insulin-induced hypoglycemia. Plasma immunoreactive ACTH (IR-ACTH) and IR-cortisol were measured for 4 h after injection of each hormone; basal levels for all subjects were less than or equal to 9 +/- 1.2 pg/ml and 4.9 +/- 0.4 micrograms/dl (mean +/- SE), respectively. AVP and oCRF, when given individually, caused rapid rises in IR-ACTH to similar peak levels of 25 +/- 6.6 and 33 +/- 4.6 pg/ml, respectively. AVP given 15 min before oCRF caused a 2.6-fold potentiation of the oCRF response, with a peak IR-ACTH of 85 +/- 4.6 pg/ml. AVP given at the same time as oCRF produced a fourfold potentiation of the peak IR-ACTH response to 132 +/- 11 pg/ml. These ACTH responses were far greater than those previously observed after 30-fold greater doses of oCRF alone. By way of comparison, insulin-induced hypoglycemia caused a peak IR-ACTH of 169 +/- 20 pg/ml. IR-ACTH returned to base line at 60-90 min after AVP alone, whereas the prolonged effect of oCRF was apparent whether it was given alone or in combination with AVP. The mean peak IR-cortisol responses to AVP, oCRF, and AVP given 15 min before oCRF were similar (16.5 +/- 0.9, 16.4 +/- 2.3, and 18.5 +/- 0.8 micrograms/dl, respectively), but the peak IR-cortisol responses to AVP and oCRF given simultaneously and to insulin-induced hypoglycemia were 1.5 and 1.7 times greater, respectively. IR-cortisol returned to base line within 2-3 h after AVP alone, but remained elevated for at least 4 h after oCRF alone or in combination with AVP. These results indicate that AVP acts synergistically with oCRF to release ACTH in man and suggest that AVP may play a physiologic role in modulating the ACTH response mediated by corticotropin-releasing factor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci111240

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Principles and Procedures of Statistics
Robinson, H. F. (1961) · Agronomy Journal · doi:10.2134/agronj1961.00021962005300050002x · Cited by 17,727
Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Self-citation
Characterization of a 41-Residue Ovine Hypothalamic Peptide that Stimulates Secretion of Corticotropin and β-Endorphin
Vale, W., Spiess, J., RIVIER, C. L., & Rivier, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Self-citation
Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965
In Vivo Corticotropin-Releasing Factor-Induced Secretion of Adrenocorticotropin, β-Endorphin, and Corticosterone*
RIVIER, C. L., Brownstein, M. J., Spiess, J., Rivier, J., & Vale, W. (1982) · Endocrinology · doi:10.1210/endo-110-1-272 · Cited by 555
Self-citation
Primary structure of corticotropin-releasing factor from ovine hypothalamus
Spiess, J., Rivier, J., Rivier, C., & Vale, W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6517 · Cited by 424
Self-citation
Isolation and sequence analysis of the human corticotropin‐releasing factor precursor gene.
Shibahara, S., Morimoto, Y., Furutani, Y., Notake, M., Takahashi, H. K., Shimizu, S., Horikawa, S., & Numa, S. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01499.x · Cited by 419
Corticotropin-Releasing Factor*
YASUDA, N., Greer, M. A., & Aizawa, T. (1982) · Endocrine Reviews · doi:10.1210/edrv-3-2-123 · Cited by 322
Rapid radioimmunoassay for corticotropin in unextracted human plasma.
Nicholson, W. E., Davis, D. R., Sherrell, B. J., & Orth, D. N. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.2.259 · Cited by 280
Self-citation
Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.
Orth, D. N., Jackson, R. V., DeCherney, G. S., DEBOLD, C. R., ALEXANDER, A. N., Island, D. P., Rivier, J., RIVIER, C. L., Spiess, J., & Vale, W. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110804 · Cited by 246
Self-citation

Show all 31 references

Research works printed but not linked: 1

[4]4. Vale, W. W., C. Rivier, J. Spiess, M. R. Brown, and J. Rivier. 1983. Corticotropin-releasing factor. In Brain Peptides. D. Krieger, M. Brownstein, and J. Martin, editors. John Wiley & Sons, Inc., New York. 961-974.

Sorted by citations

CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Self-citation
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
Psychobiological mechanisms underlying the social buffering of the hypothalamic-pituitary-adrenocortical axis: a review of animal models and human studies across development
Hostinar, C. E., Sullivan, R. M., & Gunnar, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0032671 · Cited by 739
Cushing's Syndrome
Orth, D. N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321207 · Cited by 563
Self-citation
Role of stress in the pathogenesis of the metabolic syndrome
Rosmond, R. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.05.007 · Cited by 533
Mediation by Corticotropin Releasing Factor (CRF) of Adenohypophysial Hormone Secretion
RIVIER, C. L., & Plotsky, P. M. (1986) · Annual Review of Physiology · doi:10.1146/annurev.ph.48.030186.002355 · Cited by 444
Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders?
CARTER, C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.08.025 · Cited by 432
Corticotropin-releasing hormone receptor subtypes and emotion
Steckler, T., & Holsboer, F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00170-5 · Cited by 323
The Neuroendocrinology of Chronic Fatigue Syndrome
Cleare, A. J. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0014 · Cited by 315
Mice Deficient for Both Corticotropin-Releasing Factor Receptor 1 (CRFR1) and CRFR2 Have an Impaired Stress Response and Display Sexually Dichotomous Anxiety-Like Behavior
Bale, T. L., Picetti, R., Contarino, A., Koob, G. F., Vale, W., & Lee, K. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00193.2002 · Cited by 293
Self-citation
Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma
Jiang, S., Postovit, L., Cattaneo, A., Binder, E. B., & Aitchison, K. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00808 · Cited by 288
“On receipt of the neuronal signal from the amygdala and locus coeruleus, numerous neuropeptides are released from the hypothalamus, including arginine vasopressin (AVP) and stress-induced corticotropin-releasing factor/hormone (CRF/H) (90).”
Background
Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: Implications for the pathophysiology of depression
Scott, L. V., & Dinan, T. G. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00027-7 · Cited by 285
Stress sensitivity and the development of affective disorders
Bale, T. L. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.033 · Cited by 243
Covariance between psychological and endocrine responses to pharmacological challenge and psychosocial stress: a question of timing
Schlotz, W., Kumsta, R., Layes, I., Entringer, S., Jones, A., & Wüst, S. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181810658 · Cited by 237
Cushing's disease
BERTAGNA, X. Y., Guignat, L., Groussin, L., & Bertherat, J. Y. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.001 · Cited by 225
Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review
Gibbs, D. M. (1986) · Psychoneuroendocrinology · doi:10.1016/0306-4530(86)90048-x · Cited by 193
Multiple sclerosis is associated with alterations in hypothalamic- pituitary-adrenal axis function
Michelson, D., Stone, L., Galliven, E., Magiakou, M. A., Chrousos, G. P., Sternberg, E. M., & Gold, P. W. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.3.8077372 · Cited by 175
Corticotropin-Releasing Hormone
Taylor, A. L., & Fishman, L. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807283190405 · Cited by 175
Abnormal Cortisol Secretion and Responses to Corticotropin-Releasing Hormone in Women with Hypothalamic Amenorrhea*
Biller, B. M. K., Federoff, H. J., Koenig, J. I., & Klibanski, A. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-2-311 · Cited by 173
Glucocorticoids Suppress Corticotropin-Releasing Hormone and Vasopressin Expression in Human Hypothalamic Neurons
Erkut, Z. A., Pool, C. W., & Swaab, D. F. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4881 · Cited by 157
The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development
Ring, R. H. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382241 · Cited by 142
Sex Differences in Response to Stress and Expression of Depressive-Like Behaviours in the Rat
Dalla, C., Pitychoutis, P. M., Kokras, N., & Papadopoulou‐Daifoti, Z. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_94 · Cited by 137
A Combined Test Using Desmopressin and Corticotropin-Releasing Hormone in the Differential Diagnosis of Cushing's Syndrome
Newell-Price, J. D. C., Perry, L., Medbak, S., Monson, J. P., Savage, M. O., Besser, M., & Grossman, A. B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3674 · Cited by 126
Sensitivity to stress: Dysregulation of CRF pathways and disease development
Bale, T. L. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2005.01.009 · Cited by 122
Hormonal and metabolic responses to exercise across time of day and menstrual cycle phase
Galliven, E. A., Singh, A., Michelson, D., Bina, S., Gold, P. W., & Deuster, P. A. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.6.1822 · Cited by 116
Vasopressin receptor expression and mutation analysis in corticotropin- secreting tumors
Dahia, P. L. M., Ahmed-Shuaib, A., Jacobs, R. A., Chew, S. L., Honegger, J. B., Fahlbusch, R., BESSER, G. M., & Grossman, A. B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626831 · Cited by 116
In the trout, CRH and AVT synergize to stimulate ACTH release
Baker, B. I., Bird, D. J., & Buckingham, J. C. (1996) · Regulatory Peptides · doi:10.1016/s0167-0115(96)00130-9 · Cited by 112
Anatomy of melancholia: focus on hypothalamic–pituitary–adrenal axis overactivity and the role of vasopressin
Dinan, T. G., & Scott, L. V. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00443.x · Cited by 110
Blunted adrenocorticotropin and Cortisol responses to corticotropin‐releasing hormone stimulation in chronic fatigue syndrome
Scott, L. V., Medbak, S., & Dinan, T. G. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10030.x · Cited by 106
Chronic Effects of a Nonpeptide Corticotropin-Releasing Hormone Type I Receptor Antagonist on Pituitary-Adrenal Function, Body Weight, and Metabolic Regulation
Bornstein, S., WEBSTER, E. L., Torpy, D. J., Richman, S. J., Mitsiades, N., Igel, M., Lewis, D. B., Rice, K. C., Joost, H., Tsokos, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.4.5938 · Cited by 106
Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications
Schulte, H. M., Chrousos, G. P., Gold, P. W., Booth, J. D., Oldfield, E. H., Cutler, G. B., & Loriaux, D. L. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111890 · Cited by 103
Ectopic pro-opiomelanocortin syndrome
Beuschlein, F., & Hammer, G. D. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00025-1 · Cited by 101
Stress Responsiveness of the Hypothalamic–Pituitary–Adrenal Axis: Age-Related Features of the Vasopressinergic Regulation
Goncharova, N. D. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00026 · Cited by 102
Corticotropin-releasing hormone physiology
Majzoub, J. A. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02247 · Cited by 97
Rapid Sequential Intravenous Administration of Four Hypothalamic ReleasingHormones as a Combined Anterior Pituitary Function Test in Normal Subjects*
SHELDON, W. R., DEBOLD, C. R., Evans, W. S., DeCherney, G. S., Jackson, R. V., Island, D. P., Thorner, M. O., & Orth, D. N. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-4-623 · Cited by 87
Self-citation
Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH
Salata, R. A., Jarrett, D. B., Verbalis, J. G., & Robinson, A. G. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113382 · Cited by 84
Diurnal Variation in the Response of Plasma Adrenocorticotropin and Cortisol to Intravenous Ovine Corticotropin-Releasing Hormone*
DeCherney, G. S., DEBOLD, C. R., Jackson, R. V., SHELDON, W. R., Island, D. P., & Orth, D. N. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-2-273 · Cited by 83
Self-citation
Effect of Plasma Osmolality on Pituitary-Adrenal Responses to Corticotropin-Releasing Hormone and Atrial Natriuretic Peptide Changes in Central Diabetes Insipidus
Elias, L. L. K., Antunes‐Rodrigues, J., Elias, P. C. L., & Moreira, A. C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.4.3884 · Cited by 82
Detailed kinetic analysis of adrenocorticotropin secretion by dispersed rat anterior pituitary cells in a microperifusion system: effects of ovine corticotropin-releasing factor and arginine vasopressin
WATANABE, T., & ORTH, D. N. (1987) · Endocrinology · doi:10.1210/endo-121-3-1133 · Cited by 80
Self-citation
Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis
Erkut, Z. A., Hofman, M. A., Ravid, R., & Swaab, D. F. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00098-m · Cited by 79
Vasopressin as a target for antidepressant development: an assessment of the available evidence
Scott, L. V., & Dinan, T. G. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00026-5 · Cited by 78
Effect of Altered Thyroid Hormone Levels on Hypothalamic-Pituitary-Adrenal Function*
Kamilaris, T. C., DEBOLD, C. R., PAVLOU, S. N., Island, D. P., HOURSANIDIS, A., & Orth, D. N. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-5-994 · Cited by 78
Self-citation
Chronic Imipramine Is Associated with Diminished Hypothalamic-Pituitary-Adrenal Axis Responsivity in Healthy Humans
Michelson, D., Galliven, E., Hill, L., Demitrack, M. A., Chrousos, G. P., & Gold, P. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4172 · Cited by 75
Hormonal Responses to Insulin-Induced Hypoglycemia in Man*
Watabe, T., TANAKA, K., Kumagae, M., Itoh, S., Takeda, F., Morio, K., HASEGAWA, M., HORIUCHI, T., Miyabe, S., & Shimizu, N. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-6-1187 · Cited by 75
DIAGNOSIS OF ENDOCRINE DISEASE: The role of the desmopressin test in the diagnosis and follow-up of Cushing’s syndrome
Vassiliadi, D. A., & Tsagarakis, S. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0007 · Cited by 74
The Relationship of Saline-Induced Changes in Vasopressin Secretion to Basal and Corticotropin-Releasing Hormone-Stimulated Adrenocorticotropin and Cortisol Secretion in Man*
Rittmaster, R. S., Cutler, G. B., Gold, P. W., Brandon, D. D., Tomai, T. P., Loriaux, D. L., & Chrousos, G. P. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-2-371 · Cited by 70
Pulsatile Administration of Human Corticotropin-Releasing Hormone in Patients with Secondary Adrenal Insufficiency: Restoration of the Normal Cortisol Secretory Pattern
Avgerinos, P. C., Schürmeyer, T. H., Gold, P. W., Tomai, T. P., Loriaux, D. L., Sherins, R. J., Cutler, G. B., & Chrousos, G. P. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-816 · Cited by 69
The three-way interactions between the hypothalamic-pituitary-adrenal and gonadal axes and the immune system
Torpy, D. J., & Chrousos, G. P. (1996) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(96)80014-8 · Cited by 68
AUGMENTATION OF THE RESPONSE TO CRF IN MAN: RELATIVE CONTRIBUTIONS OF ENDOGENOUS ANGIOTENSIN AND VASOPRESSIN
Milsom, S. R., Conaglen, J. V., Donald, R. A., Espiner, E. A., Nicholls, M. G., & Livesey, J. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb02998.x · Cited by 66
Consistent Reduction of ACTH responses to stimulation with CRH, Vasopressin and Hypoglycaemia in Patients with Major Depression
Kathol, R. G., Jaeckle, R. S., López, J. F., & Meller, W. H. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.155.4.468 · Cited by 66
Corticotropin-releasing factor (CRF) — a review
Emeric-Sauval, E. (1986) · Psychoneuroendocrinology · doi:10.1016/0306-4530(86)90014-4 · Cited by 57
Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei
Ogilvie, K. M., Lee, S., & RIVIER, C. L. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01082-7 · Cited by 57
Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants
Rizvi, Z. B., Aniol, H. S., Myers, T. F., Zeller, W. P., Fisher, S. G., & Anderson, C. L. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81971-7 · Cited by 56
Comparative assessment of ACTH and lipotropin plasma levels in the diagnosis and follow-up of patients with Cushing's syndrome: A study of 210 cases
Kuhn, J., Proeschel, M. F., Seurin, D., BERTAGNA, X. Y., LUTON, J. P., & Girard, F. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90443-9 · Cited by 54
High Intensity Exercise Promotes Escape of Adrenocorticotropin and Cortisol from Suppression by Dexamethasone: Sexually Dimorphic Responses
Deuster, P. A., Petrides, J. S., Singh, A. P., Lucci, E. B., Chrousos, G. P., & Gold, P. W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5110 · Cited by 54
The Role of Vasopressin in Hypothalamo‐Pituitary‐Adrenal Axis Activation during Stress: An Assessment of the Evidence
Makara, G. B., Mergl, Z., & Zelena, D. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.018 · Cited by 52
Plasma corticotropin and cortisol responses to ovine corticotropin- releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease
Dickstein, G., DEBOLD, C. R., Gaitan, D., DeCherney, G. S., Jackson, R. V., Sheldon, W. R., Nicholson, W. E., & Orth, D. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768855 · Cited by 49
Self-citation
Chronobiology of the Hypothalamic-Pituitary-Adrenal and Renin-Angiotensin-Aldosterone Systems
Angeli, A., Gatti, G., & Masera, R. G. (1992) · Springer eBooks · doi:10.1007/978-3-642-78734-8_22 · Cited by 48
Adrenocorticotropic hormone and cortisol in calves after corticotropin-releasing hormone.
Veissier, I., van Reenen, C. G., Andanson, S., & Leushuis, I. E. (1999) · Journal of Animal Science · doi:10.2527/1999.7782047x · Cited by 49
Familial vasopressin‐sensitive ACTH‐independent macronodular adrenal hyperplasia (VPs‐AIMAH): clinical studies of three kindreds
Gagliardi, L., Hotu, C., Casey, G. J., Braund, W. J., Ling, K., Dodd, T. J., Manavis, J., Devitt, P. G., Cutfield, R. G., Rudzki, Z., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03471.x · Cited by 45
A Complex Mechanism of Facilitation in Pituitary Acth Cells: Recent Single-Cell Studies
Leong, D. A. (1988) · Journal of Experimental Biology · doi:10.1242/jeb.139.1.151 · Cited by 43
Handbook of depression and anxiety
Kasper, S. F., den Boer, J. A., & Sitsen, J. M. A. (2003) · M. Dekker eBooks · Cited by 43
Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans
Torpy, D. J., Grice, J. E., Hockings, G. I., Walters, M. M., Crosbie, G. V., & Jackson, R. V. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027217 · Cited by 42
Self-citation
Aspirin Inhibits Vasopressin-Induced Hypothalamic-Pituitary-Adrenal Activity in Normal Humans
Nye, E. J., Hockings, G. I., Grice, J. E., Torpy, D. J., Walters, M. M., Crosbie, G. V., Wagenaar, M., Cooper, M., & Jackson, R. V. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3820 · Cited by 41
Self-citation
Dose Response of Adrenocorticotropin and Cortisol to the CCK-B Agonist Pentagastrin
Abelson, J. L. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00124-9 · Cited by 41
Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man
WATABE, T., TANAKA, K., KUMAGAE, M., ITOH, S., KOGURE, M., HASEGAWA, M., HORIUCHI, T., MORIO, K., TAKEDA, F., UBUKATA, E., et al. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-6-1132 · Cited by 39
The Mechanisms Underlying Autonomous Adrenocorticotropic Hormone Secretion in Cushing’s Disease
Fukuoka, H., Shichi, H., Yamamoto, M., & Takahashi, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239132 · Cited by 40
Abnormalities in response to vasopressin infusion in chronic fatigue syndrome
Altemus, M. M. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)00044-5 · Cited by 39
The combined corticotropin-releasing hormone/lysine vasopressin test discloses a corticotroph phenotype
BERTAGNA, X. Y., Coste, J., Raux-Demay, M. C., Letrait, M., & Strauch, G. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.2.390 · Cited by 39
The Effects of Cortisol, Vasopressin (AVP), and Corticotropin-Releasing Factor Administration on Pulsatile Adrenocorticotropin, α-Melanocyte-Stimulating Hormone, and AVP Secretion in the Pituitary Venous Effluent of the Horse*
Livesey, J., Donald, R. A., IRVINE, C. H. G., Redekopp, C., & Alexander, S. L. (1988) · Endocrinology · doi:10.1210/endo-123-2-713 · Cited by 37
Laboratory differentiation of Cushing's syndrome
Reimondo, G., Pia, A. R., Bovio, S., Allasino, B., Daffara, F., Paccotti, P., Borretta, G., Angeli, A., & Terzolo, M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.10.036 · Cited by 36
The effect of naloxone on adrenocorticotropin and cortisol release: evidence for a reduced response in depression
Burnett, F., Scott, L. V., Weaver, M. G., Medbak, S., & Dinan, T. G. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00127-x · Cited by 35
Corticotropin releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin
Gaillard, R. C., Riondel, A. M., LING, N. C., & Muller, A. F. (1988) · Life Sciences · doi:10.1016/s0024-3205(88)80012-2 · Cited by 35
Corticotropin-releasing hormone is produced by rat corticotropes and modulates ACTH secretion in a paracrine/autocrine fashion.
Giraldi, F. P., & Cavagnini, F. (1998) · Journal of Clinical Investigation · doi:10.1172/jci443 · Cited by 34
The HPA axis response to insulin hypoglycemia in depression
López, J. F., Kathol, R. G., Jaeckle, R. S., & Meiler, W. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90226-5 · Cited by 33
Effect of Naloxone on the Hormone Response to crf in Normal man
Conaglen, J. V., Donald, R. A., Espiner, E. A., Livesey, J., & Nicholls, M. G. (1985) · Endocrine Research · doi:10.3109/07435808509035423 · Cited by 32
Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin
Favrod-Coune, C. A., Raux-Demay, M. C., Proeschel, M. F., BERTAGNA, X. Y., Girard, F., & LUTON, J. P. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00522.x · Cited by 32
Effects of Incremental Infusions of Arginine Vasopressin on Adrenocorticotropin and Cortisol Secretion in Man*
Hensen, J., Hader, O., Bähr, V., & Oelkers, W. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-4-668 · Cited by 32
Kinetic Actions and Interactions of Arginine Vasopressin, Angiotensin-II, and Oxytocin on Adrenocorticotropin Secretion by Rat Anterior Pituitary Cells in the Microperifusion System*
Watanabe, T., Oki, Y., & Orth, D. N. (1989) · Endocrinology · doi:10.1210/endo-125-4-1921 · Cited by 31
Self-citation
Regulation of gene expression of vasotocin and corticotropin-releasing hormone receptors in the avian anterior pituitary by corticosterone
Kang, S. W., & Kuenzel, W. J. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.04.018 · Cited by 31
Desmopressin augments pituitary–adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers
Scott, L. V., Medbak, S., & Dinan, T. G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00232-7 · Cited by 30
Dose Response of Arginine Vasopressin to the CCK-B Agonist Pentagastrin
Abelson, J. L. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00182-2 · Cited by 30
Adrenocorticotropin and Cortisol Responses to Vasopressin during Pregnancy*
Goland, R., Wardlaw, S. L., MacCarter, G. D., Warren, W. B., & Stark, R. I. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-257 · Cited by 30
Multiple signaling pathways convey central and peripheral signals to regulate pituitary function: Lessons from human and non-human primate models
Vázquez-Borrego, M. C., Gahete, M. D., Martínez‐Fuentes, A. J., Fuentes-Fayos, A. C., Castano, J. P., Kineman, R. D., & Luque, R. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.12.007 · Cited by 30
Endocrine Response to High-Intensity Exercise: Dose-Dependent Effects of Dexamethasone
Deuster, P. A., Petrides, J. S., Singh, A. P., Chrousos, G. P., & Poth, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6444 · Cited by 31
Effects of Severalin VitroSystems on the Potencies of Putative Adrenocorticotropin Secretagogues on Rat Anterior Pituitary Cells*
Watanabe, T., & Orth, D. N. (1988) · Endocrinology · doi:10.1210/endo-122-5-2299 · Cited by 28
Self-citation
Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: A translational approach
Heinzmann, J.-M., Kloiber, S. M., Mattos, G. E., Bielohuby, M., Schmidt, M. V., Palme, R., Holsboer, F., Uhr, M., Ising, M., & Touma, C. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.008 · Cited by 29
Stimulation of the pituitary-adrenal axis with a low dose [Arg8]-vasopressin in depressed patients and healthy subjects
Wied, C. C. G., Westenberg, H. G. M., Koppeschaar, H. P. F., Thijssen, J. H. H., & van Ree, J. M. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90003-q · Cited by 27
Vasopressin–neurophysin and DST in major depression: Relationship with suicidal behavior
Pitchot, W., Scantamburlo, G., Pinto, E., Hansenne, M., Reggers, J., Ansseau, M., & Legros, J.-J. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.07.007 · Cited by 26
Corticotropin-Releasing Hormone and the Sympathoadrenal System Are Major Mediators in the Effects of Peripherally Administered Exendin-4 on the Hypothalamic-Pituitary-Adrenal Axis of Male Rats
Gil‐Lozano, M., Romaní‐Pérez, M., Outeiriño‐Iglesias, V., Vigo, E., González-Matías, L. C., Brubaker, P. L., & Mallo, F. (2014) · Endocrinology · doi:10.1210/en.2013-1718 · Cited by 26
Neuroendocrine Responses to Emotional Stress: Possible Interactions Between Circulating Factors and Anterior Pituitary Hormone Release
Meyerhoff, J. L., Oleshansky, M. A., Kalogeras, K. T., Mougey, E. H., Chrousos, G. P., & Granger, L. G. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5799-5_6 · Cited by 25
Pathophysiologic and Somatic Investigations of Hypothalamic‐Pituitary‐Adrenal Axis Activation in Patients with Depression
Michelson, D., & Gold, P. W. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09610.x · Cited by 25
Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation
Hockings, G. I., Grice, J. E., Crosbie, G. V., Walters, M. M., Jackson, A. J., & Jackson, R. V. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.2.404 · Cited by 24
Self-citation
Control of Adrenocorticotropin Secretion and Adrenocortical Sensitivity in Neurohypophysectomized Conscious Dogs: Effects of Acute and Chronic Vasopressin Replacement*
Raff, H., Merrill, D., Skelton, M. M., Brownfield, M. S., & Cowley, A. W. (1988) · Endocrinology · doi:10.1210/endo-122-4-1410 · Cited by 24
Expression of stress hormones AVP and CRH in the hypothalamus of Mus musculus following water and food deprivation
Yadawa, A. K., & Chaturvedi, C. M. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2016.03.005 · Cited by 22
Hypersensitivity of the hypothalamic-pituitary-adrenal axis to naloxone in post-traumatic stress disorder
Hockings, G. I., Grice, J. E., Ward, W. K., Walters, M. M., Jensen, G. R., & Jackson, R. V. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90096-v · Cited by 22
Self-citation
Naloxone‐induced ACTH release: mechanism of action in humans
Jackson, R. V., Grice, J. E., Hockings, G. I., & Torpy, D. J. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02612.x · Cited by 21
Self-citation
Adrenocorticotropin Hyperresponsiveness in Myotonic Dystrophy Following Oral Fenfluramine Administration
Grice, J. E., Jackson, J., Penfold, P. J., & Jackson, R. V. (1991) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1991.tb00241.x · Cited by 21
Self-citation
Effect of Ovine Corticotropin-Releasing Hormone Administered During Insulin-Induced Hypoglycemia on Plasma Adrenocorticotropin and Cortisol*
DeCherney, G. S., DEBOLD, C. R., Jackson, R. V., SHELDON, W. R., Kamilaris, T. C., Island, D. P., & Orth, D. N. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-6-1211 · Cited by 21
Self-citation
Gene Regulation System of Vasopressin and Corticotoropin-Releasing Hormone
Yoshida, M. (2008) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s424 · Cited by 20

Authors: DeBold, C. R., Sheldon, W. R., DeCherney, G. S., Jackson, R. V., Alexander, A. N., Vale, W., Rivier, J., & Orth, D. N.
Affiliations: Vanderbilt University (US)
Salk Institute for Biological Studies (US)
ORCID: Vale, W
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1984-02-01
Volume: 73
Issue: 2
Pages: 533-538
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci111240
PMC: PMC425045
OpenAlex: W2007636157
Cited by: 189
References: 31
Citations by year: 2026: 1 · 2025: 2 · 2023: 1 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 3
FWCI: 3.88
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (2t32am007061-12)
Medical Research Council (19429)
National Health and Medical Research Council
National Cancer Institute
Topics: Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords: vasopressin, ACTH, ACTH release, corticotropin-releasing factor, ovine CRF, synergistic hormone interaction, cortisol, insulin-induced hypoglycemia, hypothalamic-pituitary-adrenal axis, stress response, plasma ACTH, plasma cortisol, human volunteers, dose-response relationship
MeSH terms: Adrenocorticotropic Hormone, Adult, Arginine Vasopressin, Corticotropin-Releasing Hormone, Drug Synergism, Humans, Hydrocortisone, Insulin, Kinetics, Male, Peptides, Vasopressins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks